Clinical Trial Update: Asciminib as Maintenance Treatment After Cellular Therapies for Adults With Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating asciminib as maintenance therapy after cellular therapies in adults with Philadelphia chromosome-positive acute lymphob…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Drugs mentioned

• Asciminib (asciminib)

Snippet

Sponsor: City of Hope Medical Center | Conditions: B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 | Phase 1 | Status: NOT_YET_RECRUITING